Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mark Girton"'
Publikováno v:
Surgical Pathology Clinics. 16:385-400
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::523b7f68be4e1ed1a86e006f0516ebf4
https://doi.org/10.1016/j.path.2023.01.004
https://doi.org/10.1016/j.path.2023.01.004
Autor:
Narendranath Epperla, Adam Zayac, Daniel J. Landsburg, Mitchell Hughes, Allison M. Bock, Grzegorz S. Nowakowski, Emily C. Ayers, Mark Girton, Marie Hu, Amy Beckman, Shaoying Li, L. Jeffrey Medeiros, Julie E. Chang, Adam Stepanovic, Habibe Kurt, Jose Sandoval-Sus, M. Ali Ansari-Lari, Shalin K. Kothari, Anna Kress, Mina L Xu, Pallawi Torka, Suchitra Sundaram, Stephen D Smith, Kikkeri N Naresh, Yasmin Karimi, David A. Bond, Umar Farooq, Mahak Saad, Andrew Matthew Evens, Karan Pandya, Seema G Naik, Manali Kamdar, Bradley M. Haverkos, Reem Karmali, Timothy S Oh, Julie M. Vose, Heather Nutsch, Paul Rubinstein, Amina Chaudhry, Adam J. Olszewski
Publikováno v:
Blood. 140:3839-3841
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9585c573387190d535bba84be29c602d
https://doi.org/10.1182/blood-2022-157105
https://doi.org/10.1182/blood-2022-157105
Publikováno v:
Journal of Hematopathology. 14:61-68
Correct subclassification of B cell lymphoma requires integration of histologic and immunohistochemical findings in addition to results of flow cytometric immunophenotyping, cytogenetic analysis, and molecular studies. Evaluation for the MYD88 L265P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c825e6827baa0341451d480f035b4e1
https://doi.org/10.1007/s12308-020-00437-1
https://doi.org/10.1007/s12308-020-00437-1
Publikováno v:
American Journal of Clinical Pathology. 158:S12-S13
As use of direct factor Xa inhibitor (direct oral anticoagulant; DOAC) therapy increases, a modified lupus anticoagulant (LAC) testing method was studied to remove interfering DOACs, allowing clinicians to evaluate patients for antiphospholipid syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4eae825aaae56d917e09f8ec55ffdc6a
https://doi.org/10.1093/ajcp/aqac126.021
https://doi.org/10.1093/ajcp/aqac126.021
Autor:
M. Ali Ansari-Lari, Brad M. Haverkos, Anna Kress, Andrew M. Evens, Yasmin Karimi, Adam J. Olszewski, Julie M. Vose, Adam Zayac, L. Jeffrey Medeiros, David A. Bond, Paul Rubinstein, Emily C. Ayers, Manali Kamdar, Amina Chaudhry, Mitchell E. Hughes, Karan Pandya, Shalin Kothari, Amy Beckman, Suchitra Sundaram, Mina L. Xu, Stephen D. Smith, Marie Hu, Daniel J. Landsburg, Mark Girton, Habibe Kurt, Reem Karmali, Timothy S. Oh, Heather Nutsch, Jose Sandoval-Sus, Seema Naik, Pallawi Torka, Shaoying Li, Narendranath Epperla, Kikkeri N Naresh
Publikováno v:
Blood. 138:455-455
Background: The term HGBL, NOS was introduced by the World Health Organization (WHO) in 2016 for aggressive B-cell lymphomas with Burkitt lymphoma-like (BLL) or blastoid cytomorphology that lack double-hit genetics and do not meet criteria for other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71449df7109d74cee16469463918cbf1
https://doi.org/10.1182/blood-2021-144308
https://doi.org/10.1182/blood-2021-144308
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 199:e1-e2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::501da1ab9550ee49b36fc57ab556644e
https://doi.org/10.1164/rccm.201806-1056im
https://doi.org/10.1164/rccm.201806-1056im